XXE5XY9Measurement of Infection, Other Positive Blood/Isolated Colonies Bimodal Phenotypic Susceptibility Technology, New Technology Group 9

  • Billable / Specific Code
ICD-10-PCS XXE5XY9
CMS Source: FY 2027 ICD-10-PCS dataset. Effective Oct 1, 2026 – Sep 30, 2027.FacebookXLinkedInPrint

XXE5XY9 is a billable ICD-10-PCS procedure code for Measurement of Infection, Other Positive Blood/Isolated Colonies Bimodal Phenotypic Susceptibility Technology, New Technology Group 9. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027). The root operation Measurement involves determining the level of a physiological or physical function at a point in time. The Alphabetic Index lists this code under Selux Rapid AST Platform. In AHRQ's Clinical Classifications Software (CCSR), this procedure falls under Measurement and monitoring, NEC.

Code Identity

ICD-10-PCS Code
XXE5XY9
Billable Status
Yes — Valid for Submission
Code Describes
Measurement of Infection, Other Positive Blood/Isolated Colonies Bimodal Phenotypic Susceptibility Technology, New Technology Group 9
Short Description
Measure Pos Bld/Isol Colonies Bimod Pheno Susc New Tech 9
Parent Code

PCS Table Breakdown

Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.

PositionDesignationValueMeaning
1SectionXNew Technology
2Body SystemXPhysiological Systems
3OperationEMeasurement
4BodyPart5Circulatory
5ApproachXExternal
6Device/Substance/TechnologyYInfection, Other Positive Blood/Isolated Colonies Bimodal Phenotypic Susceptibility Technology
7Qualifier9New Technology Group 9

In the ICD-10-PCS Alphabetic Index

The FY 2027 ICD-10-PCS Alphabetic Index refers to XXE5XY9 as Selux Rapid AST Platform. These index entries lead to this code:

Direct entry for this code
New Technology, Other Positive Blood/Isolated Colonies Bimodal Phenotypic Susceptibility Technology
Direct entry for this code

To code selux rapid AST platform, open the FY 2027 ICD-10-PCS Alphabetic Index at Selux Rapid AST Platform. The entry lists XXE5XY9 directly as a complete, billable code.

Browse the full ICD-10-PCS Alphabetic Index →

Clinical Classification (CCSR)

AHRQ groups this procedure code into these clinical categories.

MAM015
Measurement and monitoring, NEC
Clinical domain: Measurement and Monitoring

Similar Procedure Codes

Questions About XXE5XY9

Is XXE5XY9 a billable code?

Yes. This is a complete seven-character ICD-10-PCS code, specific enough to report Measurement of Infection, Other Positive Blood/Isolated Colonies Bimodal Phenotypic Susceptibility Technology, New Technology Group 9 on inpatient claims from October 1, 2026 through September 30, 2027.

What is the ICD-10-PCS code for selux Rapid AST Platform?

The ICD-10-PCS Alphabetic Index lists Selux Rapid AST Platform under code XXE5XY9, Measurement of Infection, Other Positive Blood/Isolated Colonies Bimodal Phenotypic Susceptibility Technology, New Technology Group 9, billable on inpatient claims in fiscal year 2027.

What do the characters in XXE5XY9 mean?

The code breaks down character by character: the 1st character X is the Section (New Technology); the 2nd character X is the Body System (Physiological Systems); the 3rd character E is the Operation (Measurement); the 4th character 5 is the BodyPart (Circulatory); the 5th character X is the Approach (External); the 6th character Y is the Device/Substance/Technology (Infection, Other Positive Blood/Isolated Colonies Bimodal Phenotypic Susceptibility Technology); the 7th character 9 is the Qualifier (New Technology Group 9).